113 related articles for article (PubMed ID: 28533090)
1. Identification of AHCY inhibitors using novel high-throughput mass spectrometry.
Uchiyama N; Dougan DR; Lawson JD; Kimura H; Matsumoto SI; Tanaka Y; Kawamoto T
Biochem Biophys Res Commun; 2017 Sep; 491(1):1-7. PubMed ID: 28533090
[TBL] [Abstract][Full Text] [Related]
2. Mutations in S-adenosylhomocysteine hydrolase (AHCY) affect its nucleocytoplasmic distribution and capability to interact with S-adenosylhomocysteine hydrolase-like 1 protein.
Grbeša I; Kalo A; Belužić R; Kovačević L; Lepur A; Rokić F; Hochberg H; Kanter I; Simunović V; Muńoz-Torres PM; Shav-Tal Y; Vugrek O
Eur J Cell Biol; 2017 Sep; 96(6):579-590. PubMed ID: 28647132
[TBL] [Abstract][Full Text] [Related]
3. Discovery of S-adenosyl-L-homocysteine hydrolase inhibitors based on non-adenosine analogs.
Nakao A; Suzuki H; Ueno H; Iwasaki H; Setsuta T
Bioorg Med Chem Lett; 2014 Sep; 24(17):4336-40. PubMed ID: 25022879
[TBL] [Abstract][Full Text] [Related]
4. Knock-down of AHCY and depletion of adenosine induces DNA damage and cell cycle arrest.
Belužić L; Grbeša I; Belužić R; Park JH; Kong HK; Kopjar N; Espadas G; Sabidó E; Lepur A; Rokić F; Jerić I; Brkljačić L; Vugrek O
Sci Rep; 2018 Sep; 8(1):14012. PubMed ID: 30228286
[TBL] [Abstract][Full Text] [Related]
5. TNFalpha-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase.
Matthews RP; Lorent K; Mañoral-Mobias R; Huang Y; Gong W; Murray IV; Blair IA; Pack M
Development; 2009 Mar; 136(5):865-75. PubMed ID: 19201949
[TBL] [Abstract][Full Text] [Related]
6. Colorimetric assay for S-adenosylhomocysteine hydrolase activity and inhibition using fluorosurfactant-capped gold nanoparticles.
Lin JH; Chang CW; Wu ZH; Tseng WL
Anal Chem; 2010 Nov; 82(21):8775-9. PubMed ID: 20945873
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human S-adenosyl-homocysteine hydrolase in vitro and identification of its potential inhibitors.
Hao W; Li Y; Shan Q; Han T; Li W; He S; Zhu K; Li Y; Tan X; Gu J
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1209-1215. PubMed ID: 28933241
[TBL] [Abstract][Full Text] [Related]
8. Thymine-based molecular beacon for sensing adenosine based on the inhibition of S-adenosylhomocysteine hydrolase activity.
Nieh CC; Tseng WL
Biosens Bioelectron; 2014 Nov; 61():404-9. PubMed ID: 24914852
[TBL] [Abstract][Full Text] [Related]
9. Functional and Pathological Roles of AHCY.
Vizán P; Di Croce L; Aranda S
Front Cell Dev Biol; 2021; 9():654344. PubMed ID: 33869213
[TBL] [Abstract][Full Text] [Related]
10. Lead discovery for mammalian elongation of long chain fatty acids family 6 using a combination of high-throughput fluorescent-based assay and RapidFire mass spectrometry assay.
Takamiya M; Sakurai M; Teranishi F; Ikeda T; Kamiyama T; Asai A
Biochem Biophys Res Commun; 2016 Nov; 480(4):721-726. PubMed ID: 27793673
[TBL] [Abstract][Full Text] [Related]
11. AHCYL1 senses SAH to inhibit autophagy through interaction with PIK3C3 in an MTORC1-independent manner.
Huang W; Li N; Zhang Y; Wang X; Yin M; Lei QY
Autophagy; 2022 Feb; 18(2):309-319. PubMed ID: 33993848
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights of SAH enzyme catalysis and implication for inhibitor design.
Wei H; Zhang R; Wang C; Zheng H; Li A; Chou KC; Wei DQ
J Theor Biol; 2007 Feb; 244(4):692-702. PubMed ID: 17069857
[TBL] [Abstract][Full Text] [Related]
13. Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase.
Converso A; Hartingh T; Fraley ME; Garbaccio RM; Hartman GD; Huang SY; Majercak JM; McCampbell A; Na SJ; Ray WJ; Savage MJ; Wolffe C; Yeh S; Yu Y; White R; Zhang R
Bioorg Med Chem Lett; 2014 Jun; 24(12):2737-40. PubMed ID: 24813734
[TBL] [Abstract][Full Text] [Related]
14. Assays for methionine γ-lyase and S-adenosyl-L-homocysteine hydrolase based on enzymatic formation of CdS quantum dots in situ.
Saa L; Mato JM; Pavlov V
Anal Chem; 2012 Nov; 84(21):8961-5. PubMed ID: 23083214
[TBL] [Abstract][Full Text] [Related]
15. X-ray crystal structure and binding mode analysis of human S-adenosylhomocysteine hydrolase complexed with novel mechanism-based inhibitors, haloneplanocin A analogues.
Lee KM; Choi WJ; Lee Y; Lee HJ; Zhao LX; Lee HW; Park JG; Kim HO; Hwang KY; Heo YS; Choi S; Jeong LS
J Med Chem; 2011 Feb; 54(4):930-8. PubMed ID: 21226494
[TBL] [Abstract][Full Text] [Related]
16. S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia.
Altintas E; Sezgin O
Med Hypotheses; 2004; 63(5):834-7. PubMed ID: 15488656
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma S-adenosylhomocysteine-accelerated atherosclerosis is associated with epigenetic regulation of endoplasmic reticulum stress in apoE-/- mice.
Xiao Y; Huang W; Zhang J; Peng C; Xia M; Ling W
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):60-70. PubMed ID: 25359864
[TBL] [Abstract][Full Text] [Related]
18. Discovery and structural analyses of S-adenosyl-L-homocysteine hydrolase inhibitors based on non-adenosine analogs.
Nakao A; Suzuki H; Ueno H; Iwasaki H; Setsuta T; Kashima A; Sunada S
Bioorg Med Chem; 2015 Aug; 23(15):4952-4969. PubMed ID: 26037610
[TBL] [Abstract][Full Text] [Related]
19. A Turkish patient with novel AHCY variants and presumed diagnosis of S-adenosylhomocysteine hydrolase deficiency.
Bas H; Cilingir O; Tekin N; Saylisoy S; Durak Aras B; Uzay E; Erzurumluoglu Gokalp E; Artan S
Am J Med Genet A; 2020 Apr; 182(4):740-745. PubMed ID: 31957987
[TBL] [Abstract][Full Text] [Related]
20. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
